Portfolio Update

RNS Number : 9859W

Intl. Biotechnology Trust PLC

18 June 2008

 

18 June 2008

NEW PRIVATE PORTFOLIO COMPANIES

The Board of International Biotechnology Trust plc (the 'Company') notes that investments have been made in the unquoted portfolio since the half-yearly results for the six-months ended 29 February 2008 were announced on 15 April 2008.

The Company has invested in two new unquoted medical device companies, both based in Minneapolis, USA: £1.1m (US$2.0m) in Entellus, focused on treating sinusitis; and £0.6m (US$1.14m) in EBR systems which is developing a wireless cardiac stimulation device. Additional investments have also been made in the following existing portfolio companies: £0.16m (US$0.3m) in Itero, £1.3m (US$2.4m) in EUSA Pharma, £0.08m (US$0.15m) in Dynogen and £0.36m (US$0.7m) in Intranasal.  

Enquiries:

Kate Bingham/David Pinniger

SV Life Sciences Managers LLP          

Investment Manager                                         Tel: [phone]

Louise Richard

Schroder Investment Management Limited        Tel: [phone]

 

END

 

 

PFUBGGDLSDBGGII